Government ❯ Politics ❯ Health Policy

FDA

Drug Approval Leadership Changes Marty Makary Vaccine Regulation Vaccine Approval Mifepristone Trump Administration Leadership Vaccine Controversy Hydroxychloroquine Access Pharmaceutical Industry Leadership Issues Commissioner Issues Regulations Commissioner Regulatory Decisions Commissioner Actions Commissioner Removal Regulatory Actions Personnel Decisions Resignation Drug Safety Drug Regulation Regulatory Affairs Commissioner Nomination

Reports Say Trump Signs Off on Plan to Remove FDA Chief Marty Makary

The reported move follows clashes over drug reviews, flavored vapes, abortion‑pill policy.

FDA Chief Makary Faces Intensifying Pressure as Vape Approvals and Staff Shake-Up Fuel Scrutiny

Former FDA Biologics Chief Peter Marks Joins Eli Lilly to Lead Infectious Disease and Molecule Discovery

FDA Moves to Authorize Leucovorin for Cerebral Folate Deficiency Linked to an Autism Subgroup

FDA Backs Leucovorin for Cerebral Folate Deficiency as White House Promotes Autism Use